Precision Exercise Using Myostatin/Follistatin Ratio in Obese Adults (PRECISION-MASL)
A Precision Exercise Approach Using Myostatin/Follistatin Ratio Stratification to Improve Lean Body Mass and Metabolic Health: A 12-Month Randomized Clinical Trial in Obese North Indian Adults
This study evaluates whether a 12-month supervised progressive resistance training program improves lean body mass and metabolic health in obese North Indian adults aged 35-60 years. Asian Indians are uniquely predisposed to sarcopenic obesity-the coexistence of excess body fat and reduced muscle mass-which significantly increases the risk of type 2 diabetes and cardiovascular disease.
Participants will be stratified into High-Ratio and Low-Ratio groups based on their baseline Myostatin/Follistatin (MSTN/FST) ratio, an biological index of muscle catabolism versus growth. Half of the participants in each stratum will undergo a 12-month supervised resistance training program, while the other half will receive standard lifestyle advice. The primary goal is to determine whether baseline MSTN/FST ratio predicts the extent of muscle mass gain and whether reducing this ratio mediates improvements in insulin resistance and systemic inflammation.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Background & Scientific Rationale: Sarcopenic obesity is a major driver of cardiometabolic risk in Asian Indians due to low baseline lean mass combined with high visceral adiposity. Myostatin (MSTN) acts as a primary negative regulator of muscle growth, whereas follistatin (FST) acts as its circulating antagonist. Previous genetic research demonstrates that gain-of-function Myostatin gene variants are strongly associated with lower lean body mass and increased adiposity in North Indians. This trial prospectively tests whether the serum MSTN/FST ratio functions as a precision biomarker to stratify exercise response and guide targeted exercise interventions.
Study Objectives:
Determine the efficacy of a 12-month supervised resistance training program on total lean body mass (LBM) and physical performance compared to lifestyle control, testing for treatment interaction across baseline MSTN/FST strata.
Characterize the molecular adaptations of the myostatin axis by measuring serum myostatin, follistatin, MSTN/FST ratio, and peripheral blood mononuclear cell (PBMC) MSTN mRNA expression at baseline and 12 months.
Assess whether reductions in the MSTN/FST ratio mediate improvements in insulin resistance (HOMA-IR), systemic inflammatory markers (IL-6, TNF-α, hsCRP), and muscle quality.
Trial Design & Interventions: A single-center, ratio-stratified, 1:1 parallel-group randomized controlled superiority trial of 200 obese North Indian adults.
Resistance Training Arm (n=100): 3 supervised sessions per week (60 minutes per session) at 70-80% 1-repetition maximum (1RM) using progressive resistance overload reassessed every 8 weeks.
Control Arm (n=100): Standard individualized dietary and physical activity advice per national guidelines without supervised exercise sessions.
Outcome Assessments: Dual-energy X-ray absorptiometry (DEXA) for total LBM, appendicular lean mass, and body fat percentage; handgrip dynamometry and 1RM testing for strength; quantitative ELISA for serum biomarkers; real-time qRT-PCR (2-ΔΔCt method) for PBMC MSTN mRNA expression; and standardized biochemical panels for glycemic and inflammatory profiles.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Dr Surya Prakash Bhatt, PhD
- Número de telefone: 919810085720
- E-mail: suryabhat@gmail.com
Locais de estudo
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, Índia, 110016
- Diabetes Foundation India
-
Contato:
- Dr Surya Prakash Bhatt, PhD
- Número de telefone: 919810085720
- E-mail: suryabhat@gmail.com
-
Investigador principal:
- Professor Anoop Misra, MD
-
Subinvestigador:
- Dr Surya Prakash Bhatt, PhD
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age 35-60 years inclusive
- BMI ≥ 25 kg/m² (Asian Indian cut-off for overweight)
- Body fat percentage ≥ 30% in women or ≥ 25% in men measured by DEXA
- Sedentary lifestyle, defined as less than 150 minutes per week of moderate-intensity physical activity by self-report and validated by wearable activity tracker at screening
- Non-diabetic (fasting plasma glucose < 126 mg/dL and HbA1c < 6.5%)
- Willing and able to provide written informed consent
- Resident within 25 km of Fortis C-DOC for the full 12-month trial duration
Exclusion Criteria:
- Known Type 2 Diabetes Mellitus
- Established cardiovascular disease, heart failure, cerebrovascular accident, or peripheral arterial disease
- Chronic kidney disease
- Active malignancy or history of malignancy within 5 years
- Use of anabolic steroids, systemic corticosteroids, growth hormone, or immunosuppressants within 3 months of enrolment
- Any musculoskeletal, neurological, or orthopaedic condition precluding participation in supervised resistance training
- Pregnancy or lactation
- Participation in any structured supervised exercise programme in the preceding 6 months
- HIV infection or other active chronic infection
- Thyroid disorder not on stable replacement therapy for at least 3 months
- Severe end-organ damage
- Inability to provide informed consent
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Progressive Resistance Training
Supervised progressive resistance training program consisting of 3 sessions per week for 12 months (60 minutes per session) at 70-80% 1-repetition maximum (1RM). Includes multi-joint upper and lower body exercises (leg press, knee extension/flexion, hip abduction, lat pulldown, seated row, chest/overhead press, crunches) with formal load reassessment every 8 weeks. |
12-month supervised progressive resistance training program, 3 sessions per week (60 min/session) at 70-80% 1-repetition maximum (1RM) featuring progressive overload reassessed every 8 weeks. Includes leg press, knee extension/flexion, hip abduction, lat pulldown, seated row, chest press, overhead press, and abdominal crunches. A single 60-minute structured lifestyle counseling session at baseline providing individualized dietary and physical activity advice according to ICMR consensus guidelines for Asian Indians, supplemented with written educational materials. |
|
Comparador Ativo: Standard Lifestyle Advice
A single structured 60-minute lifestyle counseling session at baseline providing individualized dietary advice and physical activity recommendations based on ICMR national guidelines for Asian Indians, along with educational materials and follow-up assessments at 6 and 12 months. |
12-month supervised progressive resistance training program, 3 sessions per week (60 min/session) at 70-80% 1-repetition maximum (1RM) featuring progressive overload reassessed every 8 weeks. Includes leg press, knee extension/flexion, hip abduction, lat pulldown, seated row, chest press, overhead press, and abdominal crunches. A single 60-minute structured lifestyle counseling session at baseline providing individualized dietary and physical activity advice according to ICMR consensus guidelines for Asian Indians, supplemented with written educational materials. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Percentage change in total lean body mass
Prazo: Baseline, 6 months, 12 months
|
Percentage change in total lean body mass (LBM) from baseline to 6 and 12 months measured by DEXA, comparing the resistance training and control groups and assessing differences between High-Ratio and Low-Ratio MSTN/FST strata. |
Baseline, 6 months, 12 months
|
|
Change in Serum Myostatin Concentration
Prazo: Baseline, 12 months
|
Change in serum myostatin levels quantified in duplicate via validated sandwich ELISA (intra-assay CV < 8%, inter-assay CV < 10%). |
Baseline, 12 months
|
|
Change in Serum Follistatin Concentration
Prazo: Baseline, 12 months
|
Change in serum follistatin levels quantified in duplicate via validated sandwich ELISA |
Baseline, 12 months
|
|
Change in Serum Myostatin/Follistatin (MSTN/FST) Ratio
Prazo: Baseline, 12 months
|
Integrated dynamic index of anabolic-catabolic balance calculated as serum myostatin (pg/mL) divided by serum follistatin (pg/mL). |
Baseline, 12 months
|
|
Change in PBMC MSTN mRNA Expression
Prazo: Baseline, 12 months
|
Relative gene expression of myostatin mRNA isolated from Peripheral Blood Mononuclear Cells (PBMCs) and measured via real-time quantitative PCR using the Livak 2 -ΔΔCT method normalized to GAPDH. |
Baseline, 12 months
|
|
Change in Systemic Inflammatory Markers
Prazo: Baseline, 6 months, 12 months
|
Quantification of circulating serum Interleukin-6 (IL-6; pg/mL), Tumor Necrosis Factor-alpha (TNF-α; pg/mL), and high-sensitivity C-Reactive Protein (hsCRP; mg/L) via high-sensitivity immunoassay methods. |
Baseline, 6 months, 12 months
|
|
Change in Skeletal Muscle Quality
Prazo: Baseline, 6 months, 12 months
|
Evaluation of muscle quality calculated as DEXA-derived muscle mass relative to strength, combined with ultrasound assessment of quadriceps muscle thickness and echo intensity. |
Baseline, 6 months, 12 months
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Appendicular Lean Mass (ASMI)
Prazo: Baseline, 6-month, and 12-month.
|
Measured by DEXA (kg/m²) |
Baseline, 6-month, and 12-month.
|
|
Handgrip Strength
Prazo: Baseline, 6-month, and 12-month.
|
Measured using a calibrated hand dynamometer (kg) |
Baseline, 6-month, and 12-month.
|
|
Lower-Body Muscle Strength
Prazo: Baseline, 6-month, and 12-month.
|
Measured by 1-repetition maximum (1RM) in leg press (kg) |
Baseline, 6-month, and 12-month.
|
|
Gait Speed
Prazo: Baseline, 6-month, and 12-month.
|
Measured by 4-metre timed walk test (seconds or m/s) |
Baseline, 6-month, and 12-month.
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: Professor Anoop Misra, MD, Diabetes Foundation, India
Publicações e links úteis
Publicações Gerais
- Helsen MM, van den Broeke MR, van de Wal RS, van de Berg WJ, van Meijgaard E, Davis CH, Li Y, Goodwin I. Elevation changes in Antarctica mainly determined by accumulation variability. Science. 2008 Jun 20;320(5883):1626-9. doi: 10.1126/science.1153894. Epub 2008 May 29.
- Bhatt SP, Nigam P, Misra A, Guleria R, Luthra K, Jain SK, Qadar Pasha MA. Association of the Myostatin gene with obesity, abdominal obesity and low lean body mass and in non-diabetic Asian Indians in north India. PLoS One. 2012;7(8):e40977. doi: 10.1371/journal.pone.0040977. Epub 2012 Aug 20.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- Diabetes Foundation India
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .